Miyauchi Eiji, Osako Syousei, Arikawa Ryo, Oketani Naoya, Ohishi Mitsuru
Department of Cardiology, Kagoshima City Hospital, Kagoshima, JPN.
Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima, JPN.
Cureus. 2025 Feb 27;17(2):e79779. doi: 10.7759/cureus.79779. eCollection 2025 Feb.
A novel approach for iatrogenic femoral artery pseudoaneurysm (IFAP) using a suture-mediated closure device and bidirectional guidewire percutaneously and intravascularly will be presented in this case report. We report a case of a 73-year-old male patient who faced a complication due to an IFAP following a percutaneous coronary intervention. Manual compression and thrombin injection combined with intravascular balloon inflation were not effective. We then inserted a guidewire percutaneously to use a suture-mediated closure device, but it could not pass through the pseudoaneurysm neck into the common femoral artery. We then attempted a novel technique involving bidirectional guidewire crossing to use the suture-mediated closure device. First, two guidewires were inserted into the pseudoaneurysm cavity percutaneously and intravascularly. Second, the intravascular guidewire was replaced with a snare using a microcatheter to catch the percutaneous guidewire and pull it through the pseudoaneurysm neck into the femoral artery. Third, the percutaneous guidewire was replaced with a 0.035 guidewire to use the suture-mediated closure device. Finally, we confirmed that the IFAP disappeared angiographically. Our new approach could be an alternative method for treating difficult cases. Additional studies may be required to evaluate the long-term safety and efficacy of this approach.
本病例报告将介绍一种使用缝合介导闭合装置和双向导丝经皮血管内治疗医源性股动脉假性动脉瘤(IFAP)的新方法。我们报告一例73岁男性患者,在经皮冠状动脉介入治疗后出现IFAP并发症。手动压迫、注射凝血酶联合血管内球囊扩张均无效。然后我们经皮插入导丝以使用缝合介导闭合装置,但导丝无法穿过假性动脉瘤颈部进入股总动脉。接着我们尝试了一种涉及双向导丝交叉的新技术来使用缝合介导闭合装置。首先,经皮血管内将两根导丝插入假性动脉瘤腔内。其次,使用微导管将血管内导丝换成圈套器,以捕获经皮导丝并将其拉过假性动脉瘤颈部进入股动脉。第三,将经皮导丝换成0.035导丝以使用缝合介导闭合装置。最后,血管造影证实IFAP消失。我们的新方法可能是治疗困难病例的替代方法。可能需要进一步研究来评估该方法的长期安全性和有效性。